# Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers

> **NCT03685084** · PHASE1 · COMPLETED · sponsor: **Allecra** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AAI101 i.v.
- **DRUG:** Saline 0.9% infusion
- **DRUG:** Piperacillin i.v.
- **DRUG:** Cefepime i.v.

## Key facts

- **NCT ID:** NCT03685084
- **Lead sponsor:** Allecra
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-10
- **Primary completion:** 2014-01-13
- **Final completion:** 2014-01-13
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03685084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03685084, "Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03685084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*